Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
Conditions
Lung Cancer
Conditions: official terms
Lung Neoplasms
Conditions: Keywords
lung cancer
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
Detailed Description
OBJECTIVES:

- Examine the mutational status of the EGFR pathway in tumor and blood samples from patients with lung cancer.

- Correlate the EGFR pathway mutations in these samples with clinical outcomes of these patients.

OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway mutations in DNA.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: DISEASE CHARACTERISTICS:

- Histologically or cytologically confirmed lung cancer

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- May have received prior EGFR inhibitors
Location
University of California Davis Cancer Center
Sacramento, California, United States
Status: Recruiting
Contact: Clinical Trials Office - University of California Davis Cancer - 916-734-3089
Start Date
May 2005
Completion Date
December 2016
Sponsors
University of California, Davis
Source
University of California, Davis
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page